Supervised Exercise for Transplant Recipients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a supervised exercise program can benefit individuals undergoing allogeneic HCT, a type of bone marrow transplant. The study consists of two parts: one for participants who begin exercising before their transplant and another for those who start after their initial hospital stay. The goal is to determine if these exercise programs are feasible and beneficial for patients. This trial may suit individuals aged 60 or older with blood cancer, planning for a transplant soon, and experiencing increased difficulty with everyday activities. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance recovery and quality of life for future transplant patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on a supervised exercise program for transplant recipients.
What prior data suggests that this exercise program is safe for transplant recipients?
Research shows that exercise programs are generally safe for individuals who have undergone a hematopoietic stem cell transplant (HSCT). Studies have found that these activities can improve physical health without causing harm. For example, one study found that supervised exercise programs, similar to those in cardiac rehabilitation, are well-tolerated even by individuals with serious health conditions, such as heart transplants.
Other research confirms that exercise is safe for HSCT recipients and can enhance physical abilities and overall quality of life. Additionally, evidence indicates that exercise is not only safe but also beneficial for individuals with blood-related cancers.
In summary, these findings suggest that participating in a supervised exercise program with professional guidance is safe and beneficial for transplant recipients.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how tailored exercise programs can benefit transplant recipients before and after their procedures. Unlike typical recovery protocols that might not emphasize structured physical activity, this trial investigates supervised exercise both as a preparatory step (Prehab) and as rehabilitation (Rehab) after transplant. The Prehab program aims to strengthen patients even before they undergo hematopoietic cell transplantation (HCT), potentially improving outcomes. Meanwhile, the Rehab program focuses on maintaining and enhancing physical function post-transplant, especially in older adults. By examining these structured exercise regimens, researchers hope to uncover new ways to boost recovery and quality of life for transplant patients.
What evidence suggests that this exercise program is effective for transplant recipients?
Research has shown that exercise programs can greatly enhance fitness and quality of life for transplant recipients. One study found that patients in these programs improved their fitness levels by 16% to 25%. In this trial, participants will be divided into two cohorts: Cohort A (Prehab) and Cohort B (Rehab). Cohort A will engage in a supervised exercise program before their hematopoietic stem cell transplant (HSCT), while Cohort B will begin their exercise program after discharge from their initial hospital stay for HSCT. Exercise also reduces tiredness and enhances overall well-being. For patients who have undergone an HSCT, exercise helps maintain physical activity and may improve survival chances post-transplant. Strength training, in particular, prevents muscle loss and reduced activity. Overall, evidence supports that exercise positively impacts recovery and quality of life for transplant recipients.23678
Who Is on the Research Team?
Shannon McCurdy, MD
Principal Investigator
Penn Medicine
Are You a Good Fit for This Trial?
This trial is for older adults (60+) who are either pre-frail or frail and are planning to undergo or have undergone an allogeneic hematopoietic cell transplant (HCT) due to a blood cancer. Participants will be split into two groups: one that starts the exercise program before HCT and another that begins after HCT.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Prehabilitation
Pre-frail and frail subjects attend at least twice weekly exercise sessions with a physical therapist and complete an exercise program at home prior to admission for HCT
Rehabilitation
All patients 60 years and older attend at least weekly exercise sessions with a physical therapist and complete an exercise program at home through Day +100 after HCT
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Exercise Program (Cohort A Prehab)
- Exercise Program (Cohort B Rehab)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Abramson Cancer Center of the University of Pennsylvania
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Lead Sponsor